Live from the NIH registry
Studies recruiting near Tampa right now
Top 25 of 1,335 recruiting studies, sorted by proximity — each links to its official registry page
Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia
Phase 1
Interventional 40 participants sought
St. Joseph's Children's Hospital - Center for Bleeding and Clotting Disorders — Tampa, Florida (3.4 mi)
· Sponsor: Bleeding and Clotting Disorders Institute Peoria, Illinois
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Saint Joseph's Hospital/Children's Hospital-Tampa — Tampa, Florida (3.4 mi)
· Sponsor: National Cancer Institute (NCI)
Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma
Melanoma Stage III, Melanoma Stage IV
Phase 2
Interventional 90 participants sought
Moffitt Cancer Center — Tampa, Florida (3.4 mi)
· Sponsor: H. Lee Moffitt Cancer Center and Research Institute
A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome)
Myelodysplastic Syndrome, Acute Myeloid Leukemia
Phase 1
Interventional 24 participants sought
Moffitt Cancer Center — Tampa, Florida (3.4 mi)
· Sponsor: M.D. Anderson Cancer Center
Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy
Chronic Graft-versus-host Disease (cGVHD)
Phase 2
Interventional 120 participants sought
Moffitt Cancer Center — Tampa, Florida (3.4 mi)
· Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Gonorrhea, Chlamydia
Phase 4
Interventional 760 participants sought
University of Florida — Tampa, Florida (3.4 mi)
· Sponsor: Westat
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Breast Cancer
Phase 3
Interventional 450 participants sought
Moffitt Cancer Center-McKinley Campus — Tampa, Florida (3.4 mi)
· Sponsor: Hoffmann-La Roche
A Study of HS235 for Treatment of Pulmonary Arterial Hypertension (PAH) in Adults
Pulmonary Arterial Hypertension
Phase 1, Phase 2
Interventional 90 participants sought
Investigational Site-102 — Tampa, Florida (3.4 mi)
· Sponsor: 35Pharma Inc
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
USF Diabetes and Endocrinology Center — Tampa, Florida (3.4 mi)
· Sponsor: Medtronic MiniMed, Inc.
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
Multiple Myeloma
Phase 1
Interventional 127 participants sought
Moffitt Cancer Center /ID# 279068 — Tampa, Florida (3.4 mi)
· Sponsor: AbbVie
Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea
Sleep Apnea, Chronic Nasal Congestion
Phase 4
Interventional 52 participants sought
Usf Asthma Allergy and Immunology Cru — Tampa, Florida (3.4 mi)
· Sponsor: University of South Florida
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
Generalized Myasthenia Gravis
N/A
Observational 500 participants sought
Clinical Trial Site — Tampa, Florida (3.4 mi)
· Sponsor: Alexion Pharmaceuticals, Inc.
A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS
Advanced Solid Tumors
Phase 1, Phase 2
Interventional 83 participants sought
Comprehensive Hematology Oncology — St. Petersburg, Florida (21.1 mi)
· Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC)
Phase 1
Interventional 604 participants sought
Lee Moffitt Cancer Center — Tampa, Florida (3.4 mi)
· Sponsor: Revolution Medicines, Inc.
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Solid Tumor, Adult, Metastatic Breast Cancer
Phase 1
Interventional 392 participants sought
Moffitt Cancer Center — Tampa, Florida (3.4 mi)
· Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Breast Neoplasms, Triple Negative Breast Neoplasms
Phase 3
Interventional 2,400 participants sought
Florida Cancer Specialists - North ( Site 7002) — St. Petersburg, Florida (21.1 mi)
· Sponsor: Merck Sharp & Dohme LLC
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Tampa, Florida (3.4 mi)
· Sponsor: AstraZeneca
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial Cancer, Bladder Cancer
Phase 2, Phase 3
Interventional 630 participants sought
Research Site — St. Petersburg, Florida (21.1 mi)
· Sponsor: Daiichi Sankyo
A Study of Buntanetap in Participants With PD
Parkinson's Disease (PD), Deep Brain Stimulation
Phase 2, Phase 3
Interventional 500 participants sought
University of South Florida (USF) - University of South Florida College of Medicine - Parkinson's Di — Tampa, Florida (3.4 mi)
· Sponsor: Annovis Bio Inc.
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Retina Vitreous Associates of Florida — St. Petersburg, Florida (21.1 mi)
· Sponsor: Genentech, Inc.
A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic Stem Cell Transplant (HSCT) or a Solid Organ Transplant (SOT)
Cytomegalovirus (CMV)
Phase 3
Interventional 80 participants sought
Johns Hopkins All Children's Hospital - Main - PIN — St. Petersburg, Florida (21.1 mi)
· Sponsor: Takeda
A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer
Advanced or Metastatic Colorectal Cancer
Phase 1, Phase 2
Interventional 225 participants sought
H Lee Moffitt Cancer Center — Tampa, Florida (3.4 mi)
· Sponsor: Janssen Research & Development, LLC
Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)
Pediatric Cancer
N/A
Observational 35 participants sought
Moffitt Cancer Center — Tampa, Florida (3.4 mi)
· Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Implementing a Decision Support Tool to Prevent Community-Acquired Pressure Injury in Spinal Cord Injury (SCI) in the Spinal Cord Injury Clinic
Spinal Cord Injury, Pressure Injury
N/A
Interventional 808 participants sought
James A. Haley Veterans' Hospital, Tampa, FL — Tampa, Florida (3.4 mi)
· Sponsor: VA Office of Research and Development
A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
N/A
Observational 30 participants sought
Suncoast Neuroscience Associates, Inc. — St. Petersburg, Florida (21.1 mi)
· Sponsor: Takeda